Start Disrupting - “Always think about what the end game is like. How you can go from where you are now, to the very end.” with Webster Santos, Professor at Virginia Tech

“Always think about what the end game is like. How you can go from where you are now, to the very end.” with Webster Santos, Professor at Virginia Tech

10/12/21 • 37 min

Webster discusses his research with drug discovery and therapeutic areas, and is co-founder of Flux Therapeutics, Inc.

Webster Santos bio: https://chem.vt.edu/people/faculty/teaching-and-research/wsantos.html
Prof. Webster Santos received his BS and Ph.D. from the University of Virginia under Prof. Timothy Macdonald. Following his doctoral studies, he moved to Harvard University as a Ruth Kirschtein NIH fellow with Prof. Gregory Verdine. At Harvard, he performed chemical biology studies targeting RNA structures as well as HIV-1 integrase. In 2006, he started as an assistant professor of chemistry at Virginia Tech and was promoted to associate then full professor in 2018. He held a chaired position as the Blackwood Junior Faculty fellow of Life Science and is currently the Agnes and Cliff Lilly faculty fellow of drug discovery. He is a co-founder of three biotech companies and received the Schug Research Award as well as an Innovator’s award at Virginia Tech. He is on the editorial advisory board of current topics in medicinal chemistry, medicinal research reviews as well as boron in the Americas. His current research centers on developing drugs towards fatty liver disease, cancer, and multiple sclerosis, synthetic methodology of installing boron and silicon onto carbon bonds and chemical biology of targeting HIV-1 RNAs.

Webster discusses his research with drug discovery and therapeutic areas, and is co-founder of Flux Therapeutics, Inc.

Previous Episode

Don’t be Common: Lessons from a Lone Wolf - Interview with John Olver, President & CEO of Emisshield

Words spoken by John Olver, President & CEO of Emisshield, during the #StartDisrupting podcast with Brett Malone, Ph.D. President & CEO of the Virginia Tech Corporate Research Center (VTCRC).
Spotlight story: The 3,100°F Impact

Have you ever considered how many things we use in daily life here on earth that originated from NASA technology? GPS, medical devices, audio conference bridge technology, among many, all got their start in space!

In August 2021, Dr. John Olver, President and CEO of Emissield, Inc. became the 85th inductee into the Space Technology Hall of Fame for contributions to life-changing technologies emerging from global space programs. Emisshield Inc. and NASA Ames, also accepted the organizational award. Read full story here.

Next Episode

From Virginia Tech student to CEO of TORC with Michael Fleming: Saving lives through self-driving trucks

In this episode, Brett Malone, Ph.D., VTCRC President/CEO, talks with Michael about TORC, the region's strengths and how it has helped the company, his vision for autonomous trucking and more.
Michael Fleming official bio

Torc Robotics, a pioneer in self-driving vehicles {website}

Torc Robotics, headquartered in Blacksburg, Virginia, is an independent subsidiary of Daimler Truck AG, the global leader and pioneer in trucking. Founded in 2005 at the birth of the self-driving vehicle revolution, Torc has 16 years of experience in pioneering safety-critical, self-driving applications. Torc offers a complete self-driving vehicle software and integration solution and is currently focusing on commercializing self-driving trucks. “Trucking is the backbone of the U.S. economy, delivering food and products to every community in the country,” said Torc CEO Michael Fleming. “Daimler has led innovation in trucking for more than a century, from the first truck to driver assist technology. Torc is working with Daimler Truck to commercialize self-driving trucks to make our roads safer and better fulfilling our mission of saving lives.”
#self-driving #entrepreneur #virginiatech #hokies #vtcrc #torc